Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are multipotent stem cells located at the basal layer of the epidermis that divide and differentiate into new skin cells. They maintain skin homeostasis by replacing dead skin cells and repair minor skin injuries naturally. However, EpiSCs cannot heal severe wounds such as third-degree burns or diabetic ulcers, which require clinical intervention.

Cultured epidermal autografts (CEAs) are laboratory-grown skin grafts created by culturing a patient's own EpiSCs with intact skin tissue on specialized biomaterials. When placed on severe wounds, the EpiSCs in the graft promote wound repair and closure. Because the cells originate from the patient's own body, immune rejection is minimized, making CEAs an effective treatment used successfully for over three decades.

Autografts use the patient's own skin tissue, reducing immune rejection risk and promoting natural healing. However, harvesting skin from an unaffected area creates a secondary wound that must heal alongside the primary injury, complicating treatment. For patients with extensive burns, allografts from donor tissue may be used temporarily to promote endogenous skin regeneration, though they are immunologically rejected within weeks.

EpiSCs reduce scar formation through exosome-mediated mechanisms. EpiSC-derived exosomes are extracellular vesicles containing proteins and RNAs that transport microRNAs to injured sites. In rodent models, these exosomes promote wound healing and prevent scarring, offering a therapeutic approach to minimize undesirable scar tissue that lacks sweat glands and limits movement.

Exosomes are extracellular vesicles containing biomolecules such as proteins and microRNAs. EpiSC-derived exosomes transport these molecules to injured sites, promoting wound healing and preventing scarring. This mechanism represents an emerging therapeutic strategy for improving outcomes in severe wound treatment by leveraging the regenerative properties of epidermal stem cells.

Studies in animal models demonstrate that epidermal stem cells can regenerate other epithelia, including the cornea, the outermost layer of the eye. This finding suggests broader clinical applications for EpiSCs in treating various epithelial injuries beyond severe skin wounds, though ongoing research continues to explore these therapeutic possibilities.

Epidermal stem cells are multipotent because they can divide and differentiate into multiple types of new skin cells, maintaining tissue diversity and function. Their multipotency enables them to replace various cell types lost during normal skin turnover and minor injuries, making them essential for skin homeostasis and the foundation for clinical applications like cultured epidermal autografts.